Malaria parasite prevalence · people at risk of malaria
Non‐pyrethroid‐like indoor residual spraying (IRS) plus… leads to lower malaria parasite prevalence compared with ITNs alone (high certainty).
1 finding from 1 review
RR 0.61 [0.42, 0.88]
16394 participants
High
EIR · people at risk of malaria
1 finding from 1 review
no estimate extracted
5 participants
Very low
Anaemia prevalence · people at risk of malaria
Non‐pyrethroid‐like indoor residual spraying (IRS) plus… showed no clear difference in anaemia prevalence compared with ITNs alone (low certainty).
1 finding from 1 review
RR 0.71 [0.38, 1.31]
4288 participants
Low
Stress symptoms ( · healthcare workers
3 findings from 1 review
no estimate extracted
3 studies · 87 participants
Very low
no estimate extracted
2 studies · 152 participants
Very low
no estimate extracted
1 study · 161 participants
Very low
Intervention not reported
ACQ responders at 6 months ‐ TRIPLE vs DUAL№ of participants: 7881(5 RCTs)
The intervention may leads to higher ACQ responders at 6 months ‐ TRIPLE vs DUAL№ of participants: 7881(5… (low certainty).
1 finding from 1 review
Intervention not reported
ACQ responders at 12 months ‐ TRIPLE vs DUAL№ of participants: 6204(4 RCTs)
It is very uncertain whether the intervention changes ACQ responders at 12 months ‐ TRIPLE vs DUAL№ of participants:… (very low certainty).
1 finding from 1 review
Intervention not reported
All cause SAEs ‐ TRIPLE vs DUAL№ of participants: 8192(6 RCTs)
The intervention showed no clear difference in all cause SAEs ‐ TRIPLE vs DUAL№ of participants: 8192(6 RCTs) (high certainty).
1 finding from 1 review
Intervention not reported
Severe exacerbations ‐ TRIPLE vs DUAL№ of participants: 2540(2 RCTs)
The intervention showed no clear difference in severe exacerbations ‐ TRIPLE vs DUAL№ of participants: 2540(2 RCTs) (moderate certainty).
1 finding from 1 review
Intervention not reported
Asthma‐related SAEs ‐ TRIPLE vs DUAL№ of participants: 8192(6 RCTs)
The intervention showed no clear difference in asthma‐related SAEs ‐ TRIPLE vs DUAL№ of participants: 8192(6 RCTs) (high certainty).
1 finding from 1 review
Intervention not reported
All cause AEs ‐ TRIPLE vs DUAL№ of participants: 8192(6 RCTs)
The intervention leads to lower all cause AEs ‐ TRIPLE vs DUAL№ of participants: 8192(6 RCTs) (high certainty).
1 finding from 1 review
Intervention not reported
Dropouts due to adverse event ‐ TRIPLE vs DUAL№ of participants: 8223(5 RCTs)
The intervention showed no clear difference in dropouts due to adverse event ‐ TRIPLE vs DUAL№ of participants:… (moderate certainty).
1 finding from 1 review
Intervention not reported
Moderate to severe exacerbations ‐ TRIPLE vs DUAL№ of participants: 8173(5 RCTs)
The intervention leads to lower moderate to severe exacerbations ‐ TRIPLE vs DUAL№ of participants:… (high certainty).
1 finding from 1 review
Intervention not reported
CFB in ACQ at 3 months ‐ TRIPLE vs DUAL№ of participants: 1535(1 RCT)
1 finding from 1 review
no estimate extracted
1 study · 3 participants
Moderate
Intervention not reported
CFB in ACQ at 6 months ‐ TRIPLE vs DUAL№ of participants: 5408(4 RCTs)
1 finding from 1 review
Intervention not reported
CFB in ACQ at 12 months ‐ DUAL vs TRIPLE№ of participants: 4253(4 RCTs)
1 finding from 1 review
Intervention not reported
CFB in AQLQ at 6 months ‐ TRIPLE vs DUAL№ of participants: 907(2 RCTs)
1 finding from 1 review
Intervention not reported
CFB in AQLQ at 12 months ‐ TRIPLE vs DUAL№ of participants: 3623(3 RCTs)
1 finding from 1 review
Residual kidney function (24 months) · patients receiving PD
4 findings from 1 review
no estimate extracted
1 study · 44 participants
Moderate
no estimate extracted
1 study · 44 participants
Moderate
no estimate extracted
3 studies · 110 participants
Moderate
Show 1 more finding
Decline in residual kidney function (12 months) · patients receiving PD
1 finding from 1 review
Residual kidney function (24 months) · patients receiving PD
1 finding from 1 review